Sign In
Buy PHYOF
$0.0700
+0 (+0%)
At Close: Jun 03, 2026
Percheron Therapeutics secures proposed WHO drug name for HMBD-002 cancer therapy
08:33am, Tuesday, 26'th May 2026
Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) has secured a proposed international nonproprietary name (pINN) from the World Health Organization for its...
Walmart price target lowered by UBS as Q1 results miss elevated expectations
07:48am, Monday, 25'th May 2026
Walmart Inc (NYSE:WMT, XETRA:WMT) had its price target lowered by UBS to $141 from $147 following the company’s first-quarter results, while the broker said...
Bram Goorden discusses IXICO growth plans - ICYMI
03:50am, Sunday, 24'th May 2026
IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) CEO, Bram Goorden, talked with Proactive about the company’s interim results, highlighting strong revenue growth,...
Bram Goorden discusses IXICO growth plans - ICYMI
03:06am, Sunday, 24'th May 2026
IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) CEO, Bram Goorden, talked with Proactive about the company's interim results, highlighting strong revenue growth, expanding demand in Alzheimer's disease clini
IXICO plc (PHYOF) Q2 2026 Earnings Call Transcript
05:10pm, Thursday, 21'st May 2026
IXICO plc (PHYOF) Q2 2026 Earnings Call Transcript
Zscaler set to benefit from federal tailwinds boosting fourth quarter outlook: analysts
10:30am, Thursday, 21'st May 2026
Zscaler Inc. (NASDAQ:ZS) is expected to deliver a strong fiscal third quarter when it reports results on May 26, with Jefferies analysts saying the...
IXICO contract wins provide near-total revenue visibility for current year
06:51am, Thursday, 21'st May 2026
IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging and analytics group, has secured £1.3 million of new contract work that its broker says should take the company's order book close t
IXICO wins £1.3 million in Alzheimer's and Huntington's contracts
02:24am, Thursday, 21'st May 2026
IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging and analytics group, has secured a contract win and a contract extension worth a combined £1.3 million over two years. The London-ba
UK utility investors face prolonged uncertainty after worst sell-off since privatisation era
07:23am, Tuesday, 19'th May 2026
UK utility shares face a potentially extended period of political and financial pressure after suffering their fourth-largest single-day decline since...
Cavendish sees IXICO forecasts as conservative after order book hits five-year high
06:48am, Tuesday, 19'th May 2026
Shares in IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging and biomarker analytics specialist, rose as much as 11% after interim results...
Cavendish sees IXICO forecasts as conservative after order book hits five-year high
06:01am, Tuesday, 19'th May 2026
Shares in IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging and biomarker analytics specialist, rose as much as 11% after interim results showed the company's order book at its highes
IXICO targets 15% revenue growth as order book swells and strategy takes shape
02:45am, Tuesday, 19'th May 2026
IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), a specialist in neuroscience imaging and biomarker analytics for clinical drug trials, said it expects to deliver at least 15% revenue growth for the full yea
Rigetti Computing tops Q1 earnings estimates as loss narrows
08:27am, Tuesday, 12'th May 2026
Rigetti Computing (NASDAQ:RGTI) reported first quarter results that came in above analyst expectations, as the company continued to scale its...
IXICO launches latest version of AI neuroimaging platform
03:21am, Tuesday, 12'th May 2026
IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging and biomarker analytics company, has released the tenth version of its proprietary IXI...
IXICO launches latest version of AI neuroimaging platform
02:23am, Tuesday, 12'th May 2026
IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging and biomarker analytics company, has released the tenth version of its proprietary IXI platform, bringing improvements to processing
